跳到正文
原文
MedPage Today·· 16 天前AI 评分40

新国会可能调查RFK Jr.并调整医保政策

Investigating RFK Jr., Fixing Surprise Billing Law May Be on Agenda for New Congress

AI 导读

新国会可能调查HHS前部长RFK Jr.的不当行为,并推动医保政策调整,如重新审视医保费用、加强价格透明度和打击医院合并等。专家认为,尽管改革面临挑战,但仍有可能在医保和健康成本控制方面取得进展。

正文

— Reversing or delaying Medicaid cuts could also be a possibility, experts suggest

November 4, 2026 • 4 min read

Changes to laws on surprise billing and price transparency as well as investigations of HHS officials could be on the menu when the Democratic-controlled Congress assumes office next year, analysts say.

"We're heartened to see a number of people elected who are likely to be public health champions," Bruce Mirken, communications co-chair at Defend Public Health, said in a phone call.

"[Sen.-elect] Abdul El-Sayed, MD, talks a lot like we do, and there are a number of other people who got elected" such as Reps.-elect Richard Pan, MD, (D-Calif.) and Mitchell Berman, RN (D-Wisc.), he said. "So there will be a lot of voices in this next Congress who will speak up for public health in a way that hasn't been happening enough in the last 2 years."

Among possible actions to be taken by the new Democratic-controlled Congress, "one is a complete and thorough investigation and airing of [HHS Secretary] Robert F. Kennedy Jr.'s record of malfeasance and disinformation, which we think should lead to articles of impeachment," he said. "This guy's guilty of public health malpractice and Congress needs to assert its authority ... and start the process of removing Mr. Kennedy."

Reasserting authority over health spending should be another top priority, Mirken said. "This administration and HHS played a lot of games with money Congress appropriated. Congress needs to dig in quickly and [fix the] damage done to disease monitoring and tracking, food safety, and health research."

Tom Miller, JD, senior fellow at the American Enterprise Institute, took a more cautious approach. "Tuesday's sweeping election results will trigger the usual post-mandate cross pressures for congressional Democrats: the urge to get some things done differently versus the strong temptation for factions to overstate and overreach their mandate to settle scores, address grievances, and pursue boundary-stretching changes not supported by the voters who just threw another set of rascals out," he said in an email. "All of this will be challenged further by the calendar pressures of starting the 2028 presidential campaign ... this week!"

"Although healthcare usually ranked in the top two or three issues most of concern to voters, it's far from clear what those voters really want (other than the generic wish for more care at lower prices)," Miller said. "Developing a list of priority targets and feasible reforms will remain challenging for the new leaders of Congress. In the meantime, competing demands on the calendar, and the limited attention span of both voters and officeholders, will make substantive legislating more aspirational than successful."

He did offer a few possibilities for action, however. "Expect few large reforms or rollbacks of recent Trump administration policy changes, but some adjustments at the margins. Some limited consensus may be available for adjustments to the flaws of the No Surprises Act and targeted shots at common villains of the moment in the health sector (hospitals, drugmakers, insurers), but expect more rhetoric than reality in what changes from current law."

Other health cost initiatives may also come under the new Congress's radar, said healthcare consultant Thomas Campanella, professor emeritus of health economics at Baldwin Wallace University in Cleveland, in an email. These include initiatives such as site-neutral hospital payments, "stricter vertical and horizontal anti-trust enforcement of hospital systems, addressing 340B abuses, and stricter enforcement of user-friendly price and ideally quality transparency," he said. "Also, there is bipartisan support for enhanced investment in primary care and rural healthcare."

Medicaid is another possible area of action, according to Edwin Park, JD, research professor at Georgetown University's Center for Children and Families in Washington. For example, the House and Senate could try to repeal the Medicaid and Supplemental Nutrition Assistance Program benefit cuts that were included in the reconciliation bill passed by Congress last summer, "and if that's not successful they may attempt to delay some of those cuts," Park said in a phone interview. There are also provisions of the Medicaid program that are expiring next year -- such as money to pay Disproportionate Share Hospitals -- that Congress will need to deal with by year's end, he added.

Park also said he expected more scrutiny of actions taken by CMS. That includes how the agency is implementing Medicaid cuts included in the reconciliation bill -- also known as the One Big Beautiful Bill.

"There have been a number of occurrences where CMS has gone well beyond what [the bill] requires, whether in [the interim final rule] for work reporting requirements ... or guidance related to financing Medicaid waivers," he said. In such cases, "CMS is going way beyond what is required. Similarly, there is little information on how prices are obtained or what drugs are subject to rebates. There is a lot of talk about how great [these deals] are but no transparency about what they actually do."

The analysts all acknowledged that many reforms have little hope of being enacted since Democrats don't have a veto-proof majority in the Senate. However, Mirken said a veto override isn't beyond the realm of possibility in today's political climate. "It's worth trying and people need to see [that] this new Congress is trying to fix the damage."

来源:MedPage Today · medpagetoday.com